Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 1071-1076

  Nagase, Takahide ^a   Ishii, Satoshi ^a   Kume, Kazuhiko ^a   Uozumi, Naonori ^a   Izumi, Takashi ^a   Ouchi, Yasuyoshi ^a   Shimizu, Takao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION PNEUMONIA; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOPATHOGENESIS; LUNG EDEMA; LUNG GAS EXCHANGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032749368     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7727     Document Type: Article

References (43)

1. Eijking, E.P., Gommers, D., So, K.L., Vergeer, M., and Lachmann, B. 1993. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Anesthesiology. 78:1145-1151.
2. Goldman, G., et al. 1992. Reactive oxygen species and elastase mediate lung permeability after acid aspiration. J. Appl. Physiol. 73:571-575.
3. Pittet, J.F., Mackersie, R.C., Martin, T.R., and Matthay, M.A. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155:1187-1205.
4. Prescott, S.M., Zimmerman, G.A., and McIntyre, T.M. 1990. Platelet-activating factor. J. Biol. Chem. 265:17381-17384.
5. Chao, W., and Olson, M.S. 1993. Platelet-activating factor: receptors and signal transduction. Biochem. J. 292:617-629.
6. Izumi, T., and Shimizu, T. 1995. Platelet-activating factor receptor: gene expression and signal transduction. Biochim. Biophys. Acta. 1259:317-333.
7. Honda, Z.-I., et al. 1991. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349:342-346.
8. Nakamura, M., et al. 1991. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266:20400-20405.
9. Ye, R.D., Prossnitz, E.R., Zou, A.H., and Cochrane, C.G. 1991. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem. Biophys. Res. Commun. 180:105-111.
10. Kunz, D., Gerard, N.P., and Gerard, C. 1992. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J. Biol. Chem. 267:9101-9106.
11. Sugimoto, T., et al. 1992. Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. Biochem. Biophys. Res. Commun. 189:617-624.
12. Bito, H., Honda, Z.-I., Nakamura, M., and Shimizu, T. 1994. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur. J. Biochem. 221:211-218.
13. Ishii, S., et al. 1996. A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem. J. 314:671-678.
14. Merlos, M., et al. 1997. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J. Pharmacol. Exp. Ther. 280:114-121.
15. Carceller, E., et al. 1994. [(3-Pyridylalkyl) piperidylidene]benzocyclo-heptapyridine derivatives as dual antagonists of PAF and histamine. J. Med. Chem. 37:2697-2703.
16. Ishii, S., et al. 1997. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16:133-142.
17. Ishii, S., et al. 1998. Impaired anaphylactic responses but intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187:1779-1788.
18. B receptor in mice. J. Appl. Physiol. 83:46-51.
19. Nagase, T., et al. 1998. Airway hyperresponsiveness to methacholine in mutant mice deficient in endothelin-1. Am. J. Respir. Crit. Care Med. 157:560-564.
20. Nagase, T., et al. 1997. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor: roles of thromboxanes and leukotrienes. Am. J. Respir. Crit. Care Med. 156:1621-1627.
21. Nagase, T., Matsui, H., Aoki, T., Ouchi, V., and Fukuchi, Y. 1996. Lung tissue behavior in the mouse during constriction induced by methacholine and endothelin-1. J. Appl. Physiol. 81:2373-2378.
22. Nagase, T., et al. 1996. Intercellular adhesion molecule-1 mediates acid aspiration-induced lung injury. Am. J. Respir. Crit. Care Med. 154:504-510.
23. Fowler, A.A., et al. 1983. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98:593-597.
24. Hudson, L.D., Milberg, J.A., Anardi, D., and Maunder, R.J. 1995. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:293-301.
25. 2 in mediating acid-aspiration injury. Surgery. 111:55-61.
26. Utsunomiya, T., et al. 1982. Modification of inflammatory response to aspiration with ibuprofen. Am. J. Physiol. 243:H903-H910.
27. Nagase, T., et al. 1991. Intravenous bolus of prednisolone decreases 15-hydroxyeicosatetraenoic acid formation in the rat model of acid aspiration. Crit. Care Med. 19:950-954.
28. 4 that mediates chemotaxis. Nature. 387:620-624.
29. 2. J. Biol. Chem. 272:16709-16712.
30. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1043-1051.
31. 2. J. Biol. Chem. 266:14850-14853.
32. 2 is phosphorylated and activated by MAP kinase. Cell. 72:269-278.
33. 2) in thrombin-stimulated platelets. J. Biol. Chem. 271:27723-27729.
34. Uozumi, N., et al. 1997. Roles of cytosolic phospholipase A2 in allergic response and parturition. Nature. 390:618-622.
35. Stewart, A.G., Dubbin, P.N., Harris, T., and Dusting, G.J. 1990. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc. Natl. Acad. Sci. USA. 87:3215-3219.
36. Folkesson, H.G., Matthay, M.A., Hébert, C.A., and Broaddus, V.C. 1995. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J. Clin. Invest. 96:107-116.
37. Chang, S.-W., Feddersen, C.O., Henson, P.M., and Voelkel, N.F. 1987. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest 79:1498-1509.
38. Miotla, J.M., Jeffery, P.K., and Hellewell, P.G. 1998. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am. J. Respir. Cell Mol. Biol. 18:197-204.
39. Tjoelker, L.W., et al. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374:549-553.
40. Smiley, P.L., Stremler, K.E., Prescott, S.M., Zimmerman, G.A., and McIntyre, T.M. 1991. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266:11104-11110.
41. Heery, J.M., et al. 1995. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96:2322-2330.
42. 2+ signaling via the platelet-activating factor receptor in macrophages. Am. J. Physiol. 272:H17-H24.
43. 2+ signaling via platelet-activating factor receptor. FEBS Lett. 314:125-129.